Table 3.
Non-PAD Control (n = 26) | IC (n = 26) | CLI (n = 26) | p | |
---|---|---|---|---|
Acylcarnitine | 43.5 ± 2.1 | 40.6 ± 2.1 | 31.1 ± 2.2 *,† | 0.001 |
Acetyl-L-carnitine | 8.7 ± 1.0 | 9.5 ± 1.1 | 9.6 ± 1.1 | 0.816 |
Propionylcarnitine | 0.351 ± 0.038 | 0.391 ± 0.037 | 0.294 ± 0.039 | 0.221 |
Malonylcarnitine | 0.006 ± 0.001 | 0.006 ± 0.001 | 0.007 ± 0.001 | 0.452 |
Hydroxypropionylcarnitine | 0.040 ± 0.002 | 0.046 ± 0.002 * | 0.047 ± 0.002 * | 0.003 |
Propenoylcarnitine | 0.017 ± 0.001 | 0.019 ± 0.001 * | 0.019 ± 0.001 * | 0.050 |
Butyrylcarnitine | 0.169 ± 0.023 | 0.168 ± 0.023 | 0.153 ± 0.024 | 0.869 |
Hydroxybutyrylcarnitine | 0.055 ± 0.015 | 0.093 ± 0.015 | 0.084 ± 0.016 | 0.189 |
Butenylcarnitine | 0.030 ± 0.001 | 0.030 ± 0.001 | 0.029 ± 0.001 | 0.879 |
Isovalerylcarnitine | 0.086 ± 0.01 | 0.092 ± 0.01 | 0.066 ± 0.01 | 0.189 |
Tiglylcarnitine | 0.023 ± 0.01 | 0.025 ± 0.01 * | 0.026 ± 0.01 * | 0.038 |
Hexoses | 5266 ± 489 | 6034 ± 479 | 5967 ± 508 | 0.476 |
Note: The values presented in the column “p-value” represent the overall difference between the three groups; bold font indicates a significant difference between groups (p < 0.05); post-hoc differences in comparisons between individual groups are denoted below as * = significant difference from non-PAD control, p < 0.05; † = significant difference from IC, p < 0.05.